Related Experiment Video
Updated: Oct 14, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study
Michael Drozd1, Mar Pujades-Rodriguez2, Fei Sun3
1Leeds Institute of Cardiovascular and Metabolic Medicine The University of Leeds Leeds UK.
Insights
Noncardiovascular deaths are common in individuals with cardiovascular diseases (CVD), with cancer being the leading cause. As CVD multimorbidity increases, so does the risk of cardiovascular and infection-related deaths, highlighting the need for personalized patient care.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Therapeutic advancements have decreased cardiovascular death rates.
- Understanding noncardiovascular death causes in cardiovascular disease (CVD) patients is crucial.
- Cardiovascular multimorbidity is an increasing concern.
Purpose of the Study:
- To determine the rates of cardiovascular and noncardiovascular death in individuals with specified CVDs.
- To analyze death causes in relation to the number of distinct CVDs present (cardiovascular multimorbidity).
Main Methods:
- Utilized UK Biobank data from 493,280 UK residents.
- Calculated proportions of death causes (cardiovascular, cancer, infection, other) based on 9 distinct self-reported CVDs.
- Employed Poisson regression to determine adjusted incidence rate ratios for death causes, controlling for confounders.
Main Results:
- Among 27,729 deaths, 20.4% were cardiovascular, 53.6% cancer, 5.0% infection, and 21.0% other causes.
- Increased cardiovascular multimorbidity correlated with higher proportions of cardiovascular and infection-related deaths.
- Individuals with ≥3 CVDs had significantly higher adjusted incidence rate ratios for cardiovascular (7.0), infection (4.4), cancer (1.5), and other (2.0) deaths compared to those without CVD.
Conclusions:
- Noncardiovascular death is prevalent in patients with cardiovascular disease (CVD), with significant variation across different CVD types.
- Cancer is the most common cause of death in this population.
- Holistic and personalized care strategies are essential for improving outcomes in individuals with CVD.
Abstract:
Background Therapeutic advances have reduced cardiovascular death rates in people with cardiovascular diseases (CVD). We aimed to define the rates of cardiovascular and noncardiovascular death in people with specified CVDs or accruing cardiovascular multimorbidity. Methods and Results We studied 493 280 UK residents enrolled in the UK Biobank cohort study. The proportion of deaths attributed to cardiovascular, cancer, infection, or other causes were calculated in groups defined by 9 distinct self-reported CVDs at baseline, or by the number of these CVDs at baseline. Poisson regression analyses were then used to define adjusted incidence rate ratios for these causes of death, accounting for sociodemographic factors and comorbidity. Of 27 729 deaths, 20.4% were primarily attributed to CVD, 53.6% to cancer, 5.0% to infection, and 21.0% to other causes. As cardiovascular multimorbidity increased, the proportion of cardiovascular and infection-related deaths was greater, contrasting with cancer and other deaths. Compared with people without CVD, those with 3 or more CVDs experienced adjusted incidence rate ratios of 7.0 (6.2-7.8) for cardiovascular death, 4.4 (3.4-5.6) for infection death, 1.5 (1.4-1.7) for cancer death, and 2.0 (1.7-2.4) for other causes of death. There was substantial heterogeneity in causes of death, both in terms of crude proportions and adjusted incidence rate ratios, among the 9 studied baseline CVDs. Conclusions Noncardiovascular death is common in people with CVD, although its contribution varies widely between people with different CVDs. Holistic and personalized care are likely to be important tools for continuing to improve outcomes in people with CVD.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Cardiovascular Drugs: Classification based on Therapeutic Indications